Profound Medical Corp Stock Net Income
| PROF Stock | USD 7.48 0.10 1.32% |
As of the 29th of January, Profound Medical holds the Semi Deviation of 2.56, coefficient of variation of 637.35, and Risk Adjusted Performance of 0.1235. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Profound Medical, as well as the relationship between them. Please check Profound Medical Corp variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Profound Medical Corp is priced some-what accurately, providing market reflects its current price of 7.48 per share. Given that Profound Medical has jensen alpha of 0.5011, we recommend you to check out Profound Medical Corp's recent market performance to make sure the company can sustain itself at a future point.
Profound Medical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 18.2327 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -25 M | -26.3 M | |
| Net Loss | -25 M | -26.3 M | |
| Net Loss | -25.8 M | -27.1 M | |
| Net Loss | (1.01) | (1.06) | |
| Net Income Per E B T | 0.90 | 0.80 |
Profound | Net Income | Build AI portfolio with Profound Stock |
Latest Profound Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Profound Medical Corp over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Profound Medical Corp financial statement analysis. It represents the amount of money remaining after all of Profound Medical Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Profound Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Profound Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (27.82 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Profound Net Income Regression Statistics
| Arithmetic Mean | (17,370,580) | |
| Coefficient Of Variation | (48.28) | |
| Mean Deviation | 7,447,274 | |
| Median | (15,222,000) | |
| Standard Deviation | 8,386,795 | |
| Sample Variance | 70.3T | |
| Range | 22.5M | |
| R-Value | (0.90) | |
| Mean Square Error | 13.6T | |
| R-Squared | 0.82 | |
| Slope | (1,502,915) | |
| Total Sum of Squares | 1125.4T |
Profound Net Income History
Other Fundumenentals of Profound Medical Corp
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Profound Medical Net Income component correlations
Profound Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Profound Medical is extremely important. It helps to project a fair market value of Profound Stock properly, considering its historical fundamentals such as Net Income. Since Profound Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Profound Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Profound Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Profound have expansion opportunities? Factors like these will boost the valuation of Profound Medical. Anticipated expansion of Profound directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Profound Medical demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (1.32) | Revenue Per Share | Quarterly Revenue Growth 0.868 | Return On Assets | Return On Equity |
Investors evaluate Profound Medical Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Profound Medical's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Profound Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Profound Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Profound Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Profound Medical's market price signifies the transaction level at which participants voluntarily complete trades.
Profound Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Profound Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Profound Medical.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Profound Medical on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Profound Medical Corp or generate 0.0% return on investment in Profound Medical over 90 days. Profound Medical is related to or competes with TriSalus Life, MaxCyte, Perspective Therapeutics, LENSAR, Anteris Technologies, Nano X, and Prenetics Global. Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that devel... More
Profound Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Profound Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Profound Medical Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.8 | |||
| Information Ratio | 0.1378 | |||
| Maximum Drawdown | 21.8 | |||
| Value At Risk | (3.80) | |||
| Potential Upside | 7.87 |
Profound Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Profound Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Profound Medical's standard deviation. In reality, there are many statistical measures that can use Profound Medical historical prices to predict the future Profound Medical's volatility.| Risk Adjusted Performance | 0.1235 | |||
| Jensen Alpha | 0.5011 | |||
| Total Risk Alpha | 0.2588 | |||
| Sortino Ratio | 0.1927 | |||
| Treynor Ratio | 0.3798 |
Profound Medical January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1235 | |||
| Market Risk Adjusted Performance | 0.3898 | |||
| Mean Deviation | 2.96 | |||
| Semi Deviation | 2.56 | |||
| Downside Deviation | 2.8 | |||
| Coefficient Of Variation | 637.35 | |||
| Standard Deviation | 3.92 | |||
| Variance | 15.33 | |||
| Information Ratio | 0.1378 | |||
| Jensen Alpha | 0.5011 | |||
| Total Risk Alpha | 0.2588 | |||
| Sortino Ratio | 0.1927 | |||
| Treynor Ratio | 0.3798 | |||
| Maximum Drawdown | 21.8 | |||
| Value At Risk | (3.80) | |||
| Potential Upside | 7.87 | |||
| Downside Variance | 7.84 | |||
| Semi Variance | 6.57 | |||
| Expected Short fall | (3.97) | |||
| Skewness | 0.823 | |||
| Kurtosis | 1.14 |
Profound Medical Corp Backtested Returns
Profound Medical appears to be somewhat reliable, given 3 months investment horizon. Profound Medical Corp maintains Sharpe Ratio (i.e., Efficiency) of 0.12, which implies the firm had a 0.12 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Profound Medical Corp, which you can use to evaluate the volatility of the company. Please evaluate Profound Medical's Risk Adjusted Performance of 0.1235, coefficient of variation of 637.35, and Semi Deviation of 2.56 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Profound Medical holds a performance score of 9. The company holds a Beta of 1.59, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Profound Medical will likely underperform. Please check Profound Medical's value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Profound Medical's historical price patterns will revert.
Auto-correlation | -0.01 |
Very weak reverse predictability
Profound Medical Corp has very weak reverse predictability. Overlapping area represents the amount of predictability between Profound Medical time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Profound Medical Corp price movement. The serial correlation of -0.01 indicates that just 1.0% of current Profound Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.01 | |
| Spearman Rank Test | 0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 0.13 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Profound Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Profound Medical Corp reported net income of (27.82 Million). This is 108.15% lower than that of the Health Care Equipment & Supplies sector and 111.68% lower than that of the Health Care industry. The net income for all United States stocks is 104.87% higher than that of the company.
Profound Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Profound Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Profound Medical could also be used in its relative valuation, which is a method of valuing Profound Medical by comparing valuation metrics of similar companies.Profound Medical is currently under evaluation in net income category among its peers.
Profound Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Profound Medical from analyzing Profound Medical's financial statements. These drivers represent accounts that assess Profound Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Profound Medical's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 291.8M | 300.8M | 235.1M | 267.5M | 307.6M | 313.8M | |
| Enterprise Value | 226.0M | 262.5M | 216.8M | 217.7M | 250.4M | 266.5M |
Profound Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Profound Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Profound Medical's managers, analysts, and investors.Environmental | Governance | Social |
Profound Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Profound Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Profound Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Profound Medical's value.| Shares | Carolina Wealth Advisors, Llc | 2025-06-30 | 2 K |
Profound Fundamentals
| Return On Equity | -1.24 | ||||
| Return On Asset | -0.62 | ||||
| Profit Margin | (2.75) % | ||||
| Operating Margin | (1.69) % | ||||
| Current Valuation | 260.67 M | ||||
| Shares Outstanding | 36.29 M | ||||
| Shares Owned By Insiders | 11.36 % | ||||
| Shares Owned By Institutions | 34.14 % | ||||
| Number Of Shares Shorted | 1.13 M | ||||
| Price To Book | 8.81 X | ||||
| Price To Sales | 19.70 X | ||||
| Revenue | 10.17 M | ||||
| Gross Profit | 10.36 M | ||||
| EBITDA | (25.59 M) | ||||
| Net Income | (27.82 M) | ||||
| Cash And Equivalents | 46.21 M | ||||
| Cash Per Share | 2.21 X | ||||
| Total Debt | 5.12 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 17.36 X | ||||
| Book Value Per Share | 1.06 X | ||||
| Cash Flow From Operations | (23.45 M) | ||||
| Short Ratio | 7.85 X | ||||
| Earnings Per Share | (1.32) X | ||||
| Target Price | 12.35 | ||||
| Number Of Employees | 142 | ||||
| Beta | 0.22 | ||||
| Market Capitalization | 281.63 M | ||||
| Total Asset | 70.23 M | ||||
| Retained Earnings | (245.17 M) | ||||
| Working Capital | 62.5 M | ||||
| Current Asset | 9 K | ||||
| Current Liabilities | 761 K | ||||
| Net Asset | 70.23 M |
About Profound Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Profound Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Profound Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Profound Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:Check out Profound Medical Piotroski F Score and Profound Medical Altman Z Score analysis. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Profound have expansion opportunities? Factors like these will boost the valuation of Profound Medical. Anticipated expansion of Profound directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Profound Medical demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (1.32) | Revenue Per Share | Quarterly Revenue Growth 0.868 | Return On Assets | Return On Equity |
Investors evaluate Profound Medical Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Profound Medical's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Profound Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Profound Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Profound Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Profound Medical's market price signifies the transaction level at which participants voluntarily complete trades.